Branding Biotech for
Funding & Acquisition

Sparking Change
Digital strategy
Digital identity
Website
2020-2022
Result

Brand Launch
Website Launch
Funding & Acquisition

2022-2024

When Kynos Therapeutics emerged as a
University of Edinburgh spinout, they had a bold
vision: to translate over a decade of academic
research into therapies that could transform the
treatment of inflammation-driven diseases. Spark
& Matter was engaged to craft the early-stage
digital identity and website that would embody
this vision and position Kynos as a leader at the
forefront of medical innovation.

TASK

Kynos needed to communicate their complex
scientific mission in a way that resonated with
potential investors, partners, and the broader
medical community.

From medical research to market results

SOLUTION

With only a logo in place, Kynos needed a brand
that bridged cutting-edge research and real-
world impact, along with a website to serve as
their digital launchpad. We developed a digital
identity that spotlighted their innovation and
positioned them as leaders in inflammation
research.

RESULTS
Investment + Acquisition

Launch

GROWTH INCREASE

£9M

secured in funding

Acquisition

by Dr.Falk in 2024
Next project

Redox